Dr Stephen Mullin holds a clinical lectureship in Neurology at The Faculty of Medicine and Dentistry at Plymouth University.  

​

 

 

In recent years it has become clear that genetics plays a key role in the development of Parkinson’s. By understanding genetic pathways, the hope is that a novel drug to prevent or slow down Parkinson’s development can be produced.  One of the most common genes implicated in Parkinson’s is glucocerebrosidase (GBA). About 10% of people with Parkinson’s in the UK carry a mutation in this gene.

​

 

 

To book a place click on the date and time below.

​

 

 

 

 

 

 

New date to be advised

​

​